Endeavour Vision is a private equity firm, focused exclusively on supporting growth-stage healthcare technology companies. The company’s mission is to transform the standard of care for millions of patients by investing in groundbreaking medical innovations. Endeavour Vision’s team offers unmatched sector and operational expertise, extensive international experience including product launches and accelerating company growth, in addition to a proven track record of successful exits. The firm's recent investments include Sophia Genetics (IPO 2021), Medartis (IPO in 2018), Vertiflex (acquired by Boston Scientific in 2019) and Symetis (acquired by Boston Scientific in 2017). The company headquarters are in Geneva, Switzerland with further presence in North America.

11

870m

Endeavour II LP, Endeavour Medtech Growth LP, Endeavour Medtech Growth II LP

22

Sophia Genetics, Medartis, Intelycare, CeQur, Willow

2000

All

Expansion - Development Capital

Medical - Life Sciences - Health Related

Europe, United States of America

Equity Financing

-

20-40m

175m

10m

40m